Cardiovascular and sympathetic effects of disrupting tyrosine 985 of the leptin receptor.
about
Obesity-associated hypertension: recent progress in deciphering the pathogenesisInvolvement of hypothalamic AMP-activated protein kinase in leptin-induced sympathetic nerve activation.Leptin receptor signaling in the hypothalamus regulates hepatic autonomic nerve activity via phosphatidylinositol 3-kinase and AMP-activated protein kinaseEffects of leptin on sympathetic nerve activity in conscious mice.Hypothalamic mTORC1 signaling controls sympathetic nerve activity and arterial pressure and mediates leptin effectsSelective leptin resistance revisited.PI3K signaling: A key pathway in the control of sympathetic traffic and arterial pressure by leptin.Neural Control of Non-vasomotor Organs in Hypertension.Leptin as a link between the immune system and kidney-related diseases: leading actor or just a coadjuvant?Neuroanatomical determinants of the sympathetic nerve responses evoked by leptin.Mechanisms mediating renal sympathetic nerve activation in obesity-related hypertension.Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity?Leptin as a Mediator of Obesity-Induced Hypertension.Viral transduction of renin rapidly establishes persistent hypertension in diverse murine strains.Arcuate neuropeptide Y inhibits sympathetic nerve activity via multiple neuropathways.Association of polymorphisms in LEPR with type 2 diabetes and related metabolic traits in a Chinese population.CNS Targets of Adipokines.Sex Differences in Leptin Control of Cardiovascular Function in Health and Metabolic Diseases.
P2860
Q34287762-90AFAC5A-C2A9-4950-83B1-6456746D70A3Q34590199-8207893C-5509-43DE-991E-86CCCD70B781Q34946123-0C4B8CB4-93A1-47A3-98E9-D461DC5E8574Q36144587-3A14AD5B-3D97-4242-A80D-A52430342C1EQ36853232-CCCA30A9-4009-4CF6-82DD-62ED1766DD80Q37147129-52C34038-3EBF-4D16-A2D6-D0B261FCEE53Q37279451-C21419A7-DA3F-4970-B7D9-22F3E3CBC5AEQ37364328-9F36CCA7-C9B8-4310-A342-F9032EFFCBB4Q38002262-8D70394B-89CF-479F-93EE-0C3F36B455C6Q38020139-BB12B3DC-6083-48C9-9E98-43088FD89F16Q38194471-CE793CD4-7A87-4B69-801A-A842BA2EF78DQ38484107-4909C770-9307-458D-B838-4BECF5A259CDQ38963692-0800BBBE-0ADD-49E9-B450-71E59B0AED57Q41643795-EC4C186B-85C6-4388-8E88-CF13C51B60C9Q41661642-CB2D8E5E-F4CE-4DB4-A14A-D22D59923431Q47158880-A163777C-B25F-4BA8-A147-2BD238AB4D32Q47978333-7804C571-8136-4AF9-955E-48C1A7D84C18Q49971662-ADEABCC0-1269-4390-90D9-46D5C4A34B8A
P2860
Cardiovascular and sympathetic effects of disrupting tyrosine 985 of the leptin receptor.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cardiovascular and sympathetic effects of disrupting tyrosine 985 of the leptin receptor.
@ast
Cardiovascular and sympathetic effects of disrupting tyrosine 985 of the leptin receptor.
@en
Cardiovascular and sympathetic effects of disrupting tyrosine 985 of the leptin receptor.
@nl
type
label
Cardiovascular and sympathetic effects of disrupting tyrosine 985 of the leptin receptor.
@ast
Cardiovascular and sympathetic effects of disrupting tyrosine 985 of the leptin receptor.
@en
Cardiovascular and sympathetic effects of disrupting tyrosine 985 of the leptin receptor.
@nl
prefLabel
Cardiovascular and sympathetic effects of disrupting tyrosine 985 of the leptin receptor.
@ast
Cardiovascular and sympathetic effects of disrupting tyrosine 985 of the leptin receptor.
@en
Cardiovascular and sympathetic effects of disrupting tyrosine 985 of the leptin receptor.
@nl
P2093
P2860
P1433
P1476
Cardiovascular and sympathetic effects of disrupting tyrosine 985 of the leptin receptor.
@en
P2093
Allyn L Mark
David J Dellsperger
Donald A Morgan
Martin G Myers
Shannon M Harlan
P2860
P304
P356
10.1161/HYPERTENSIONAHA.110.166538
P407
P577
2011-01-24T00:00:00Z